Robbins Geller Rudman & Dowd LLP Announces Pendency of Pfizer Inc. Securities Class Action

NEW YORK--()--The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Pfizer Inc. Securities Class Action:

         

MARY K. JONES, Individually and on

 

X

 

Civil Action No. 1:10-cv-03864-AKH

Behalf of All Others Similarly Situated,

:

:

CLASS ACTION

Plaintiff

:

:

SUMMARY NOTICE OF

vs.

:

PENDENCY OF CLASS ACTION

:

PFIZER INC., et al.,

:

:

Defendants.

 

X

 

TO:

 

ALL PERSONS WHO PURCHASED PFIZER INC. COMMON STOCK DURING THE PERIOD JANUARY 19, 2006 THROUGH JANUARY 23, 2009, INCLUSIVE

Currently pending in the United States District Court for the Southern District of New York is a class action brought against Pfizer Inc. (“Pfizer”) and certain individuals to recover damages for those who purchased Pfizer common stock between January 19, 2006 and January 23, 2009 (the “Class Period”). The lawsuit is captioned Mary K. Jones, Individually and on Behalf of All Others Similarly Situated v. Pfizer Inc., et al., Civil Action No. 1:10-cv-03864-AKH. Plaintiffs have been certified by the Court to represent the following “Class”:

All persons who purchased domestically or purchased on domestic exchanges Pfizer common stock between 1/19/06 and 1/23/09, inclusive, and were damaged thereby, excluding defendants and their families, directors and officers of Pfizer, and their families and affiliates.

On December 5, 2014, a Notice of Pendency of Class Action (the “Notice”) was mailed to persons who purchased Pfizer common stock during the Class Period, as reflected on the books and records of Pfizer and its transfer agent. The Notice contains important information regarding the rights of Class members, including the right to seek exclusion from the Class. If you believe you are a member of the Class as defined above, and if you have not received a copy of the Notice by mail, you are urged to request a copy free of charge by mailing your request to Pfizer Inc. Securities Litigation, c/o Gilardi & Co. LLC, Post Office Box 8040, San Rafael, California 94912-8040. You may download a copy of the Notice at www.PfizerIncSecuritiesLitigation.com.

Lead Counsel for plaintiffs and the Class are:

ROBBINS GELLER RUDMAN & DOWD LLP
655 West Broadway, Suite 1900
San Diego, California 92101

   
DATED: November 17, 2014 BY ORDER OF THE COURT

Contacts

Robbins Geller Rudman & Dowd LLP
Ellen Gusikoff Stewart, 619-231-1058

Release Summary

Robbins Geller Rudman & Dowd LLP Announces Pendency of Pfizer Inc. Securities Class Action

Robbins Geller Rudman & Dowd LLP